全文获取类型
收费全文 | 1423篇 |
免费 | 108篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 27篇 |
妇产科学 | 6篇 |
基础医学 | 128篇 |
口腔科学 | 22篇 |
临床医学 | 180篇 |
内科学 | 285篇 |
皮肤病学 | 353篇 |
神经病学 | 21篇 |
特种医学 | 99篇 |
外科学 | 125篇 |
综合类 | 66篇 |
预防医学 | 72篇 |
眼科学 | 16篇 |
药学 | 51篇 |
1篇 | |
中国医学 | 19篇 |
肿瘤学 | 60篇 |
出版年
2022年 | 11篇 |
2021年 | 17篇 |
2020年 | 16篇 |
2019年 | 23篇 |
2018年 | 23篇 |
2017年 | 21篇 |
2016年 | 23篇 |
2015年 | 50篇 |
2014年 | 49篇 |
2013年 | 46篇 |
2012年 | 81篇 |
2011年 | 73篇 |
2010年 | 58篇 |
2009年 | 61篇 |
2008年 | 66篇 |
2007年 | 61篇 |
2006年 | 53篇 |
2005年 | 41篇 |
2004年 | 50篇 |
2003年 | 55篇 |
2002年 | 34篇 |
2001年 | 44篇 |
2000年 | 32篇 |
1999年 | 34篇 |
1998年 | 39篇 |
1997年 | 37篇 |
1996年 | 45篇 |
1995年 | 34篇 |
1994年 | 30篇 |
1993年 | 21篇 |
1992年 | 24篇 |
1991年 | 12篇 |
1990年 | 17篇 |
1989年 | 18篇 |
1988年 | 28篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 20篇 |
1984年 | 15篇 |
1983年 | 17篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1976年 | 10篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1971年 | 6篇 |
排序方式: 共有1535条查询结果,搜索用时 15 毫秒
101.
102.
淋巴靶向制剂——吸附抗癌药毫微粒活性炭的研究进展 总被引:12,自引:0,他引:12
目的介绍新型淋巴靶向制剂———吸附抗癌药毫微粒活性炭的研究进展。方法依据近年来的文献 ,对活性炭的制备工艺及体内外性质等方面进行了综述。结果活性炭具有很强的吸附功能 ,普通市售活性炭仅用作脱色、吸附热原与除味等。以微粒球磨机为粉碎器械 ,可加工制备粒径达1 0 0nm左右的纳米炭微粒 ,具有优越的淋巴趋向性。结论吸附抗癌药毫微粒活性炭在临床治疗癌症方面具有良好的运用前景 相似文献
103.
104.
Schmidt A Fabrizii V Maier C Riedl M Schmidt A Kotzmann H Geyer G Luger A 《Wiener klinische Wochenschrift》2004,116(7-8):235-239
BACKGROUND: Chronic renal failure is often associated with malnutrition, and malnourished patients are subject to increased morbidity and mortality. Therefore plasma concentrations of the stomach-derived peptide hormone ghrelin, which has been shown to exert potent GH-releasing and appetite-stimulating effects, were determined and correlated with nutritional parameters. METHODS: Twenty-four patients (15 male, 9 female) undergoing hemodialysis (HD) were studied. In addition, six patients were studied before and one hour after ingestion of a meal and five were studied immediately before and at the end of the dialysis session. RESULTS: Chronic renal insufficiency was associated with significantly elevated ghrelin levels (320.1 +/- 57 fmol/mL vs. 75.6 +/- 12.4 fmol/mL in controls; p < 0.007). Plasma ghrelin concentrations were also significantly higher in the 16 normal-weight patients than in the eight overweight or obese patients (399.6 +/- 76.3 fmol/mL vs. 161.1 +/- 41.3 fmol/mL; p < 0.03). Ingestion of food induced a decrease in five out of six patients tested (mean 242.3 +/- 66.5 fmol/mL vs. 186 +/- 30.7 fmol/mL; n.s.). HD also resulted in a significant decrease of elevated ghrelin concentrations: ghrelin was in the normal range at the end of HD in four of the five patients tested. Plasma ghrelin concentrations did not correlate with nutritional parameters except for cholinesterase which was negatively correlated to ghrelin. CONCLUSION: Plasma ghrelin concentrations are elevated in HD. The fact that ghrelin concentrations are higher in normal-weight than in overweight or obese HD patients and suppressed after ingestion of a meal suggests that the regulation of ghrelin release is retained in HD patients, albeit shifted to a higher level. 相似文献
105.
Luger A 《Wiener klinische Wochenschrift》2003,115(Z2):19-22
Endocrine inactive and prolactin-secreting adenomas are the most commonly observed forms of pituitary tumors counting for more than 50 percent of diseases. In most cases first clinical symptoms can be attributed to insufficiency of the adenohypophysis which is also true for gonadotropin and thyroid stimulating hormone (TSH) producing adenomas. Clinical signs and symptoms of secondary insufficiency and primary forms of endocrine deficits do not differ significantly and the diagnosis may be hampered by involvement of more than one organ system. In contrast, symptoms and signs of ACTH or GH producing tumors are more impressive leading to diagnosis at an earlier stage. In case of corticotropic and somatotropic dysfunction dynamic tests are necessary for diagnosis. Close cooperation of endocrinologists, radiologists, and neurosurgeons is necessary for the effective workup of pituitary gland diseases. 相似文献
106.
TA Fredriksen MM Wysocka-Bakowska A Bogucki F Antonaci 《Cephalalgia : an international journal of headache》1988,8(2):93-103
Eleven female patients with cervicogenic headache (mean age, 43 years; range, 25-59 years) have been examined with the pupillometer. The pupillary diameter was examined in the basal state (that is, the status before pharmacologic stimulation) and after topically administered tyramine (2%), phenylephrine (1%), and hydroxyamphetamine (1%). A total of 51 tests were performed, 35 in the asymptomatic period and 16 during pain attacks. In a control group consisting of 26 age-matched women a total of 39 tests were carried out. Before pharmacologic stimulation (that is, in the "basal state") the pupils were smaller in the asymptomatic (pain-free) period than during pain attacks in the patients and also as compared with that of control individuals. The anisocoria (the difference in pupillary size in the same individual) observed was not significantly different between the patient group and control individuals either in the basal state (before pharmacologic stimulation) or after pharmacologic stimulation. The mydriasis resulting from the instillation of the three sympathicomimetic drugs was symmetrical in both controls and patients both during and between the pain attacks. This finding is in clear contrast to what is found in cluster headache, in which there is a "Horner-like" syndrome on the symptomatic side. These two headaches thus seem to differ essentially with regard to this variable. 相似文献
107.
108.
109.
The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview 总被引:1,自引:0,他引:1
110.
Kotzmann H Schmidt A Lercher P Schuster E Geyer G Frisch H Hörl WH Mayer G Luger A 《Nephron. Clinical practice》2003,93(2):C75-C82